As of June 2026, 1 paid clinical trial is recruiting for Sarcoma in Irving, Texas. Recruiting Sarcoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Irving has approximately 113 recruiting research studies across a wide range of therapeutic areas. Texas hosts major cancer and cardiovascular research centers including MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and the Texas Medical Center — the largest medical complex in the world.
Researchers run research studies in Irving, TX at 50 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NEXT Dallas | Advanced Solid Tumors, Colorectal Cancer, Cancer | 15 |
| NEXT Oncology | Advanced Solid Tumors, Advanced-stage Solid Tumors, Cancer | 11 |
| US Oncology Investigational Products Center (IPC) | Colorectal Neoplasms, Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer | 8 |
| NEXT Oncology Dallas | Colorectal Cancer, Mesothelioma, Pancreatic Ductal Adenocarcinoma | 8 |
| US Oncology Investigational Product Center (IPC) | Breast Cancer, Breast Neoplasms, Cancer of the Prostate | 7 |
| NEXT Oncology - Dallas | Advanced Solid Tumors, CNS Tumor, CRC | 7 |
| US Oncology Investigational Products Center | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 5 |
| Texas Center for Proton Therapy | Cancer, Neoplasms, Pediatric Patients Treated With Radiation Therapy | 3 |
| US Oncology Research Investigational Products Center | Extensive Stage Small-cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer | 3 |
| NEXT Oncology - Irving | Breast Cancer, Lung Cancer, Gastric/Esophageal Cancer | 3 |
| NEXT Dallas - Oncology Department | Advanced/Metastatic Colorectal Adenocarcinoma, MTAP-deleted Solid Tumors | 2 |
| Next Dallas | Advanced Solid Tumor, Advanced Breast Cancer, HER2-negative Breast Cancer | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| Texas Oncology Gulf Coast | Metastatic HER2-positive Breast Cancer, Metastatic Non Small Cell Lung Cancer | 2 |
| AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving | Overweight or Obesity, Psoriatic Arthritis, Radiographic Axial Spondyloarthritis | 2 |
| 015 | Advanced Solid Tumor | 1 |
| AARA Clinical Research Lone Star Arthritis and Rheumatology | Arthritis, Psoriatic | 1 |
| ALS Global | Atopic Dermatitis, Eczema, Eczema Atopic Dermatitis | 1 |
| Arizona Oncology NAHOA | Metastatic Non Small Cell Lung Cancer | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Avenzo Therapeutics Recruiting Site | Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer | 1 |
| Baylor - Christus Children's - Main Hospital | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 1 |
| Cancer Care Center of Brevard | Metastatic Non Small Cell Lung Cancer | 1 |
| Clinical Study | Obesity, Overweight, Weight Maintenance | 1 |
| Crinetics Study Site | Neuroendocrine Neoplasm, Neuroendocrine Tumors, SST2-positive Neuroendocrine Neoplasms | 1 |
| DM Clinical Research Dallas | Heart Failure | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 1 |
| Illinois Cancer Specialists | Metastatic Non Small Cell Lung Cancer | 1 |
| Invivyd Investigative Site | COVID-19 | 1 |
| Local Institution - 0017 | Schizophrenia | 1 |
| Local Institution - 0029 | Bipolar-I Disorder With Mania or Mania With Mixed Features | 1 |
| Local Institution - 0036 | Bipolar Disorder Type I With Mania | 1 |
| Local Institution - 007-999 | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 017-999 | Advanced NSCLC, Metastatic Lung Cancer | 1 |
| Local Institution - 103 | Schizophrenia | 1 |
| Maryland Oncology Hematology | Metastatic Non Small Cell Lung Cancer | 1 |
| Maryland Oncology Hematology Healing Way - USOR | Metastatic HER2-positive Breast Cancer | 1 |
| Medical Oncology Hematology Consultants | Metastatic HER2-positive Breast Cancer | 1 |
| NEXT Oncology -Dallas | Advanced Solid Tumor | 1 |
| NEXT Texas LLC - Dallas | Castration-resistant Prostate Cancer, Colorectal Cancer, Endometrium Cancer | 1 |
| NEXT, Dallas | Breast Cancer, Colo-rectal Cancer, Lung Cancer (Non-Small Cell) | 1 |
| National Neuromuscular Research Institute | CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyneuropathy | 1 |
| Next Oncology-Dallas | Locally Advanced Unresectable or Metastatic Solid Tumors | 1 |
| Nexus Health | Metastatic HER2-positive Breast Cancer | 1 |
| Precision Comprehensive Clinical Research Solutions | Rheumatoid Arthritis (RA | 1 |
| Prodromos Stem Cell Institute | Congenital Myasthenic Syndrome | 1 |
| Renal Disease Research Institute | Chronic Kidney Disease | 1 |
| Sansum Clinic 540 W - USOR | Metastatic HER2-positive Breast Cancer | 1 |
| Sl0044 50773 | Systemic Lupus Erythematosus | 1 |
| Southern Cancer Center | Metastatic Non Small Cell Lung Cancer | 1 |
Recruiting trials in Irving grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Texas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials run in Texas must also comply with the Texas Medical Privacy Act (TMPA), which extends federal HIPAA protections to a broader range of entities handling participant data.
Hipa.ai aggregates every recruiting study in Irving from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 113 recruiting clinical trials in Irving, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Irving compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Irving include Advanced Solid Tumors (10), Advanced Solid Tumor (7), Colorectal Cancer (7), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Irving on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Irving include NEXT Dallas, NEXT Oncology, US Oncology Investigational Products Center (IPC), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Irving are Cancer & tumors (58), Mental health & behavior (6), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.